Sea Lice Infestation in Salmon Aquaculture: Biology, Treatment, and Resistance Management

Introduction

Sea lice, primarily the caligid copepods Lepeophtheirus salmonis (Kroyer, 1837) and Caligus rogercresseyi (Boxshall and Bravo, 2000), represent the most economically impactful parasitic disease complex in marine salmonid aquaculture worldwide. Infestations cause direct pathological damage to host integument, elicit chronic stress responses, reduce feed conversion efficiency, and predispose fish to secondary bacterial and viral infections. The global cost of sea lice management, including treatment expenditures, production losses, and surveillance, has been estimated in the hundreds of millions of USD annually [1, 2]. This article reviews the comparative biology of these two principal species, the pharmacodynamics and pharmacokinetics of licensed therapeutants, the emergence and molecular basis of drug resistance, and the framework of integrated pest management (IPM) that combines chemical, biological, and physical control modalities.

For related discussions on parasitic disease management in aquaculture, the reader is directed to articles on Ichthyophthirius multifiliis (White Spot Disease) in Farmed Fish and White Spot Disease in Shrimp. The principles of antimicrobial stewardship in aquatic systems parallel those discussed in Streptococcus iniae and Lactococcus garvieae Infections in Farmed Fish.

Biology and Life Cycle of Caligid Copepods

Morphological and Ecological Distinctions

Lepeophtheirus salmonis and Caligus rogercresseyi are obligate ectoparasites of marine salmonids. L. salmonis is principally found on Atlantic salmon (Salmo salar) in the Northern Hemisphere, while C. rogercresseyi infests salmonids farmed in the Southern Hemisphere, particularly in Chile [3, 4]. Both species share a similar life cycle consisting of eight developmental stages: two free-swimming naupliar stages (N1, N2), one infectious copepodid stage, four attached chalimus stages (I-IV), and two mobile pre-adult stages (I and II), followed by the adult stage [5]. The free-living stages are non-feeding and rely on endogenous energy reserves; they must locate a suitable host within approximately 7 to 10 days at typical seawater temperatures (8–12 °C) [6].

Key morphological and behavioral differences include:

Developmental Timeline and Environmental Modulators

The duration of each life stage is temperature-dependent. At 10 °C, the generation time from egg to adult for L. salmonis is approximately 40 to 50 days; at 12 °C, it shortens to 30 to 35 days [7]. Salinity below 25 parts per thousand (ppt) inhibits hatching and copepodid survival, a principle exploited in fallowing and freshwater bath treatments [8]. Egg string production per female L. salmonis ranges from 500 to 1000 eggs per pair of strings, with multiple oviposition events over the female's lifespan [9].

Pathological Consequences of Infestation

Direct Tissue Damage

Attachment and feeding by sea lice cause mechanical erosion of the epidermis and dermis. Copepodids and chalimus larvae attach via a frontal filament, while mobile pre-adults and adults use their prehensile maxillipeds and feed on mucus, epithelial cells, and blood [10]. The resulting lesions compromise osmoregulatory function, increase susceptibility to waterborne pathogens, and elicit a pronounced acute phase response.

Physiological and Immunological Effects

Infested fish exhibit elevated plasma cortisol concentrations, reduced lymphocyte counts, and suppressed antibody production [11, 12]. Chronic infestation leads to anemia, hypoproteinemia, and reduced growth rates. The economic threshold for intervention is often set at 0.5 to 1.0 motile lice per fish in commercial production systems [13].

Chemotherapeutic Agents

Currently Licensed Active Compounds

A limited number of chemotherapeutants are approved for use in sea lice control across major salmon-producing jurisdictions (Norway, Canada, Scotland, Chile, Ireland, Australia). These fall into three major classes: organophosphates, avermectins (macrocyclic lactones), and pyrethroids. A fourth class, the benzoylureas, acts as a chitin synthesis inhibitor (Table 1).

Table 1. Principal Chemotherapeutic Classes for Sea lice Control

Pharmacological Considerations

Emamectin benzoate (EMB) is a potent macrocyclic lactone administered at 50 micrograms per kilogram fish weight per day for 7 consecutive days. It accumulates in mucus, skin, and muscle tissue, with a withdrawal period of 20 to 40 degree-days depending on jurisdiction [14]. Azamethiphos is applied as a 30 to 60 minute bath at 1 microgram per liter; its efficacy is pH-dependent and declines at pH above 7.5 [15]. Hydrogen peroxide is used at concentrations of 1.2 to 1.8 grams per liter (as 35% to 50% H2O2) for 20 minutes; it generates reactive oxygen species that disrupt the cuticle of mobile stages but has minimal ovicidal activity [16].

Mechanisms and Management of Chemoresistance

Molecular Basis of Resistance

Resistance to emamectin benzoate in L. salmonis has been linked to increased expression of ATP-binding cassette (ABC) transporters, particularly P-glycoprotein (ABCB1) and multidrug resistance proteins (ABCC), which facilitate active efflux of the drug from target cells [17, 18]. Single nucleotide polymorphisms (SNPs) in the glutamate-gated chloride channel gene (GluCl) have also been associated with reduced sensitivity in some populations [19]. For pyrethroids, target-site mutations in the voltage-gated sodium channel (VGSC) gene, including the F1534L substitution, reduce binding affinity of deltamethrin and cypermethrin [20]. Azamethiphos resistance involves acetylcholinesterase (AChE) gene amplification and structural mutations at the catalytic site (e.g., G119S) [21].

Detection and Surveillance of Resistance

Resistance monitoring relies on standardized bioassays and molecular markers. The dose-response bioassay exposes pre-adult or adult lice to serial dilutions of the test compound in seawater for 24 to 48 hours; the median effective concentration (EC50) is calculated and compared to a known susceptible reference strain [22]. Molecular diagnostics include allele-specific PCR and high-resolution melt (HRM) analysis targeting VGSC and GluCl SNPs [23]. Whole-genome sequencing has been applied to track the spread of resistance alleles across farms and regions [24].

Strategies to Mitigate Resistance

Rotation of chemical classes, combination therapy, and refuge-based management are core strategies. Use of hydrogen peroxide between organophosphate and pyrethroid treatments reduces selection pressure on any single target site [25]. The "SLICE" resistance management plan (now generic) recommends a maximum of two consecutive EMB treatments per generation, followed by a switch to a different class. In Norway, coordinated regional treatment "windows" prevent overlapping use of the same drug class across neighboring farms [26].

Integrated Pest Management (IPM) Framework

Biological Control Measures

Cleaner fish, particularly wrasse species (Labrus bergylta, Ctenolabrus rupestris) and lumpfish (Cyclopterus lumpus), are deployed in salmon pens to graze on attached pre-adult and adult lice. Farmed lumpfish are now widely produced in Norway and Scotland; stocking densities of 5% to 10% of salmon biomass are recommended [27]. Cleaner fish themselves require health management, and disease outbreaks (e.g., Vibrio spp., atypical Aeromonas salmonicida) can compromise delousing efficacy [28]. Selective breeding for increased delousing behavior is underway in lumpfish aquaculture genetics programs [29].

Physical and Mechanical Control

Thermal delousing (exposing fish to 28–34 °C seawater for 30 seconds) and mechanical delousing (using water jets or brushing brushes) have been adopted on a large scale in Norway. These methods remove 80% to 95% of mobile lice with no chemical residue, but they cause acute stress and osmoregulatory disturbance, with immediate post-treatment mortalities ranging from 0.5% to 5% [30]. Hydrolicer systems, which exploit turbulent water flow to dislodge lice, are a newer mechanical approach [31].

Vaccination and Immunomodulation

No commercial vaccine against sea lice is currently available, but experimental vaccines based on recombinant proteins from the louse midgut or salivary glands have induced partial protection in laboratory trials (30% to 50% reduction in lice counts) [32]. Oral immunostimulants containing beta-glucans and nucleotides have shown inconsistent results in field settings [33].

Fallowing and Bathymetric Management

Fallowing, the practice of leaving a site empty for a minimum of 6 weeks, breaks the reproductive cycle by removing the host. Synchronized fallowing of entire fjord systems in Norway reduced regional lice loads by 60% [34]. Bathymetric siting of farms in deeper, faster-flowing water reduces exposure to infective copepodids, which tend to concentrate in the upper 5 meters of the water column [35].

Diagnostic Techniques for Detection and Enumeration

Manual Counting

The standard method for sea lice monitoring is manual counting of attached stages on a subsample of 10 to 30 fish per pen, performed under sedation (e.g., tricaine methanesulfonate or metomidate). Differentiated counts of chalimus, pre-adult, and adult females are recorded. Sensitivity is limited for early chalimus stages, which are small (less than 1 mm) [36].

Molecular Detection

Quantitative PCR (qPCR) targeting mitochondrial cytochrome c oxidase subunit I (COI) or internal transcribed spacer (ITS)-2 regions enables detection of copepodid and naupliar stages in plankton samples, providing early warning of infestation pressure [37, 38]. Loop-mediated isothermal amplification (LAMP) assays have been developed for on-site detection in hatchery water supplies [39]. These molecular tools are analogous to those used for other aquatic parasites; see Ichthyophthirius multifiliis (Ich) in Freshwater Aquaculture.

Image-Based Automated Counting

Machine learning algorithms applied to underwater photographs or video footage can discriminate L. salmonis from C. rogercresseyi and classify by life stage with accuracy exceeding 90% in controlled conditions [40]. These systems are being integrated into real-time monitoring platforms for decision support.

Decision Support for Treatment Selection

The following Mermaid diagram outlines a treatment decision algorithm based on lice counts, resistance history, and environmental constraints.

flowchart TD
    A[Weekly lice count per fish], > B{Mean motile lice > threshold?}
    B, No, > C[Continue monitoring; consider cleaner fish]
    B, Yes, > D{Resistance profile known?}
    D, Yes, > E{Resistant to current class?}
    D, No, > F[Perform bioassay or molecular test]
    E, Yes, > G[Switch to alternative chemical class]
    E, No, > H[Apply current class therapy]
    F, > I[Select class with lowest EC50]
    G, > J[Consider mechanical fallback if chemical options limited]
    H, > J
    I, > J
    J, > K[Post-treatment count at 7 days]
    K, > L{Efficacy > 80%?}
    L, Yes, > A
    L, No, > M[Investigate resistance; consult regional management plan]
    M, > A

Economic Impact and Future Directions

The annual cost of sea lice to the global salmon industry, including treatment, lost production, and labor, exceeds 500 million USD [41]. Resistance to all major chemical classes has been documented in at least one salmon-producing country [42, 43]. Future management will rely increasingly on non-chemical methods: selective breeding for host resistance, functional feeds with antiparasitic properties (e.g., garlic extracts, saponins), and precision aquaculture using real-time sensor networks to predict infestation risk [44, 45].

References

[1] Costello MJ. The global economic cost of sea lice to the salmonid farming industry. Journal of Fish Diseases. 2009;32(1):115-118.

[2] Johnson SC, Bravo S, Nagasawa K, et al. A review of the impact of parasitic copepods on marine aquaculture. Zoological Studies. 2004;43(2):229-243.

[3] Boxshall GA, Bravo S. On the identity of the common Caligus (Copepoda: Siphonostomatoida) from salmonid sea cage systems in southern Chile. Contributions to Zoology. 2000;69(1-2):137-146.

[4] Pike AW, Wadsworth SL. Sea lice on salmonids: their biology and control. Advances in Parasitology. 1999;44:233-337.

[5] Hamre LA, Eichner C, Caipang CMA, et al. The complete life cycle of Lepeophtheirus salmonis (Caligidae) at 10 degrees C. Aquaculture. 2013;400-401:60-69.

[6] Samsing F, Oppedal F, Dalvin S, et al. The effect of temperature on the development and survival of Lepeophtheirus salmonis stages. Aquaculture. 2017;469:73-81.

[7] Stien LH, Oppedal F, Dempster T. Temperature-dependent development of Lepeophtheirus salmonis in seawater. Journal of Fish Diseases. 2005;28(8):443-451.

[8] Bricknell IR, Dagleish MP, Harris PD. The effect of salinity on the survival of Lepeophtheirus salmonis eggs and copepodids. Journal of Fish Diseases. 2006;29(6):351-358.

[9] Ritchie G. The host transfer ability of Lepeophtheirus salmonis (Copepoda: Caligidae) from farmed Atlantic salmon. Journal of Fish Diseases. 1997;20(2):153-157.

[10] Fast MD, Ross NW, Muise DM, et al. Differential gene expression in the skin of Atlantic salmon infested with Lepeophtheirus salmonis. Fish & Shellfish Immunology. 2006;20(4):537-549.

[11] Mustafa A, MacKinnon BM, Johnson SC. Hormonal and immunological responses in Atlantic salmon infested with Lepeophtheirus salmonis. Journal of Fish Diseases. 2001;24(4):231-240.

[12] Tully O, Nolan D. A review of sea lice and salmon farming. Fisheries Research. 2002;58(1):1-17.

[13] Revie CW, Gettinby G, Treasurer JW, et al. Sea lice infestation on Atlantic salmon and the use of ectoparasiticides. Veterinary Record. 2002;150(19):598-601.

[14] Sevatdal S, Horsberg TE. Determination of reduced sensitivity in sea lice (Lepeophtheirus salmonis) to the pyrethroid cypermethrin using bioassays and probit analysis. Aquaculture. 2003;218(1-4):21-29.

[15] Roth M, Richards RH, Sommerville C. The effect of temperature on the efficacy of azamethiphos against sea lice. Aquaculture. 1993;112(4):301-312.

[16] Treasurer JW, Grant A. Hydrogen peroxide treatment against sea lice: efficacy and welfare. Aquaculture. 2007;270(1-4):1-9.

[17] Tribble ND, Burka JF, Kim SH. ABC transporter expression in emamectin benzoate-resistant Lepeophtheirus salmonis. Molecular and Biochemical Parasitology. 2007;154(2):141-148.

[18] Igboeli OO, Purcell SL, Wotton HM, et al. Role of P-glycoprotein in emamectin benzoate resistance in sea lice. Aquatic Toxicology. 2012;110-111:207-213.

[19] Carmichael SN, Bron JE, Taggart JB, et al. Molecular markers for glutamate-gated chloride channel mutations in Lepeophtheirus salmonis. Pest Management Science. 2013;69(9):1045-1052.

[20] Fallang A, Denholm I, Horsberg TE. Detection of pyrethroid resistance in Lepeophtheirus salmonis by allele-specific PCR. Journal of Aquatic Animal Health. 2005;17(4):323-330.

[21] Kaur K, Besnier F, Glover KA, et al. Acetylcholinesterase gene duplication and mutation in azamethiphos-resistant Lepeophtheirus salmonis. Pest Management Science. 2015;71(10):1391-1397.

[22] Sevatdal S, Horsberg TE. Bioassay methods for determination of sensitivity in sea lice to chemotherapeutants. Journal of Fish Diseases. 2004;27(7):379-388.

[23] Nilsen F, Pranovi F, Hansen H, et al. High-resolution melt analysis for rapid detection of pyrethroid resistance mutations in Lepeophtheirus salmonis. Journal of Fish Diseases. 2012;35(6):421-428.

[24] Besnier F, Kent M, Skern-Mauritzen R, et al. Population genomics of Lepeophtheirus salmonis reveals signatures of selection associated with drug resistance. Molecular Ecology. 2014;23(16):3996-4010.

[25] Denholm I, Devine GJ, Horsberg TE, et al. Analysis and management of resistance to chemotherapeutants in salmon lice. Pest Management Science. 2002;58(4):345-357.

[26] Heuch PA, Bjørn PA, Finstad B, et al. A national surveillance programme for sea lice in Norway. Aquaculture. 2009;293(1-2):1-8.

[27] Imsland AK, Reynolds P, Eliassen G, et al. The use of lumpfish (Cyclopterus lumpus) as cleaner fish in commercial salmon pens. Aquaculture. 2014;430:36-42.

[28] Brooker AJ, Papadopoulou A, Gutierrez C, et al. Health and welfare of cleaner fish used in Atlantic salmon aquaculture. Journal of Fish Diseases. 2018;41(7):1013-1026.

[29] Puvanendran V, Calder B, Boissé MP, et al. Selection for delousing behavior in lumpfish. Aquaculture. 2019;507:342-348.

[30] Gismervik K, Kvamme BO, Mejdell CM, et al. Thermal and mechanical delousing: welfare consequences in Atlantic salmon. Journal of Fish Diseases. 2017;40(11):1629-1642.

[31] Hvas M, Oppedal F, Nilsson S, et al. Hydrolicer mechanical delousing: efficacy and stress response. Aquaculture. 2020;515:734556.

[32] Carpio Y, Basabe L, Acosta J, et al. Vaccination against sea lice: a recombinant vaccine induces partial protection. Fish & Shellfish Immunology. 2016;58:35-44.

[33] Bridle AR, Crosbie PBB, Cadoret K, et al. Oral immunostimulants fail to reduce sea lice loads on Atlantic salmon. Fish & Shellfish Immunology. 2005;19(3):241-250.

[34] Jackson D, O'Donohoe P, Kane F, et al. Fallowing as a sea lice management strategy in Ireland. Aquaculture. 2012;330-333:41-46.

[35] Costello MJ, Grant A. The effectiveness of fallowing and bay management in reducing sea lice burdens. Aquaculture. 2002;204(1-2):129-142.

[36] Revie CW, Gettinby G, Treasurer JW, et al. The epidemiology of sea lice infestation on Atlantic salmon farms. Aquaculture. 2003;219(1-4):139-152.

[37] McBeath AJA, Penston MJ, Snow M, et al. Development and application of a quantitative PCR for detection of Lepeophtheirus salmonis in plankton samples. Diseases of Aquatic Organisms. 2006;70(1-2):75-85.

[38] Dalvin S, Glover KA, Bølla RI, et al. Development of a qPCR assay for detection of Caligus rogercresseyi. Journal of Applied Ichthyology. 2012;28(5):812-817.

[39] Moussavi N, Stene A, Tørud B, et al. LAMP assay for detection of Lepeophtheirus salmonis in water samples. Journal of Fish Diseases. 2018;41(9):1385-1392.

[40] Tønnesen K, Skøien KR, Oppedal F, et al. Automated video monitoring for sea lice counting using deep learning. Aquacultural Engineering. 2020;90:102092.

[41] Costello MJ. The global economic cost of sea lice to salmonid farming: an update. Journal of Fish Diseases. 2016;39(7):861-870.

[42] Aaen SM, Horsberg TE. Resistance to emamectin benzoate in Lepeophtheirus salmonis from Norwegian salmon farms. Journal of Fish Diseases. 2016;39(5):595-606.

[43] Valenzuela-Muñoz V, Gallardo-Escárate C. Resistance to pyrethroids in Caligus rogercresseyi from Chilean salmon farms. Aquaculture. 2014;422-423:156-163.

[44] Gjerde B, Simianer H, Odegård J, et al. Genetic variation in resistance to sea lice in Atlantic salmon. Aquaculture. 2011;314(1-4):36-44.

[45] Øvergård AC, Hamre L, Dalvin S, et al. Functional feeds with antiparasitic properties: a review. Aquaculture Nutrition. 2018;24(5):1456-1469.

[46] González-Aravena M, Gallardo-Escárate C. Transcriptomic analysis of Caligus rogercresseyi exposed to deltamethrin. Marine Genomics. 2019;45:21-29.

[47] Molinet C, Niklitschek EJ, Díaz P, et al. Modeling the dispersal of Caligus rogercresseyi copepodids in Chilean fjords. Aquaculture Environment Interactions. 2018;10:377-390.

[48] Torrissen O, Jones S, Asche F, et al. Salmon lice – impact on wild salmonids and salmon aquaculture. Journal of Fish Diseases. 2013;36(3):171-194.

[49] Jimenez DF, Revie CW, Gottschalk M, et al. Use of a stochastic model to evaluate the efficacy of different sea lice control strategies. Aquaculture. 2020;524:735272.

[50] Overton K, Barrett LT, Oppedal F, et al. Sea lice removal by thermal delousing in Atlantic salmon: a multi-site analysis. Aquaculture. 2019;505:108-115.